Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.80
-0.56 (-4.93%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $198.68 million as of April 29, 2026. Its market cap has increased by 145.85% in one year.
Market Cap
198.68M
Enterprise Value
194.63M
1-Year Change
145.85%
Ranking
Category
Stock Price
$10.80
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $198.68M, a decrease of -36.36%. That is a compound annual growth rate of -14.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 208.98M | 50.24% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 212.21M |
| OnKure Therapeutics | 210.86M |
| OmniAb | 202.70M |
| Caribou Biosciences | 201.01M |
| Nkarta | 197.47M |
| Enlivex | 196.08M |
| Whitehawk Therapeutics | 194.92M |
| Karyopharm Therapeutics | 193.87M |